title: Follow-up of patients with systemic lupus erythematosus: what is not found in the guidelines.
abstract: A series of measures in the management of patients with systemic lupus erythematosus (SLE) which usually are not found in the lupus guidelines are discussed. In the lupus patient who has been well-controlled in the long term, the dose of hydroxychloroquine should be progressively reduced, without decreasing more than approximately 600 mg per week. We recommend taking this drug in the morning in patients with insomnia, at night in those with dyspepsia and to separate the intake of the drug from the shower (and the water should be as cool as possible) in those patients with aquagenic pruritus. We do not use prednisone on alternate days and exceptionally divide the dose into ¾ before breakfast and ¼ before dinner. Twenty to 30 min should be used per patient in every scheduled visit to assure a good clinical and human practice. We analyzed the follow-up of 112 consecutive patients from our systemic disease unit and found that 71.4% of them had symptoms that were unexplained by lupus and we only referred 8.9% of them to other specialists, probably because of our general training as internal medicine doctors. We suggest that knowing the views of SLE specialists might be of interest since, well-designed studies that would allow to progress in the understanding of this disease could be performed based on their experience.
authors.affiliation: Unidad de Enfermedades Autoinmunes Sistémicas, Servicio de Medicina Interna, Hospital Universitario «Virgen de las Nieves», Granada, España; Coordinador de la Línea Lupus del Grupo de Enfermedades Autoinmunes Sistémicas (GEAS) de la Sociedad Española de Medicina Interna (SEMI). Electronic address: jjimenezalonso@gmail.com.
authors.forename: J
authors.initials: J
authors.lastname: Jiménez-Alonso
authors.forename: J A
authors.initials: JA
authors.lastname: Vargas-Hitos
authors.forename: N
authors.initials: N
authors.lastname: Navarrete-Navarrete
authors.forename: M
authors.initials: M
authors.lastname: Zamora-Pasadas
authors.forename: S
authors.initials: S
authors.lastname: Aguilar-Huergo
authors.forename: L
authors.initials: L
authors.lastname: Jáimez
authors.forename: J M
authors.initials: JM
authors.lastname: Sabio
mesh_terms: D005500:Follow-Up Studies; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis; D011241:Prednisone
chemical_list: D011241:Prednisone
keywords: Autoimmune diseases; Clinical guidelines; Enfermedades autoinmunes; Guías de práctica clínica; Internal medicine; Lupus eritematoso sistémico; Medicina interna; Systemic lupus erythematosus